At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 5,451 enrolled
Drug / intervention
Evidence-based tailored fall prevention +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
In Brief
A Phase 3 clinical trial evaluating Evidence-based tailored fall prevention and Usual care for Accidental Falls and Wounds and Injuries. Completed, enrolled 5,451 participants across 10 sites.
Detailed Summary
The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAccidental Falls, Wounds and Injuries
CountriesUnited States
CollaboratorsYale University, University of California, Los Angeles, Healthcare Partners, The University of Texas Medical Branch, Galveston, University of Pittsburgh Medical Center, Johns Hopkins University, Sinai Health System, Reliant Medical Group, Partners HealthCare, University of Michigan, University of Iowa, Essentia Health, Wake Forest University, National Institute on Aging (NIA), Patient-Centered Outcomes Research Institute, National Institutes of Health (NIH)
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartAug 2015
Primary CompletionDec 2019
Study CompletionJan 2020
TodayJul 2026
First PostedJun 19, 2015
Enrollment StartAug 1, 2015
Primary CompletionDec 1, 2019
Study CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 11.0 years ago
Interventions
Evidence-based tailored fall preventionother
Usual careother